Becker's Hospital Review

17 CEO / STRATEGY Mayo Clinic to increase some wages by 6% By Alexis Kayser R ochester, Minn.-based Mayo Clinic is boosting pay 6 percent for some workers, marking its largest across- the-board wage jump in two decades, the Star Tri- bune reported Oct. 5. The raise will apply to 64,500 allied health workers across the five-state health system, including nurses, technicians, security and maintenance workers. Workers covered by union contracts will not receive an increase, JoEllen Frain, the clinic's chair of human resources, told the newspaper. Workers making less than $21 per hour will receive ex- tra raises, increasing their pay 8 percent to 9 percent, the newspaper reported. Additionally, new workers and current workers moving into new roles at the clinic will see a 3 percent increase in pay ranges. Staff members who are long-tenured and near the top of their pay range will receive lump-sum payments to boost their 2023 compensation by 6 percent, the news- paper said. The pay boosts aim to address the impacts of COVID-19, worker shortages and inflation on clinic workers, Ms. Frain told the newspaper. "I've been at Mayo for 23 years and this really is proba- bly one of the most challenging times that I've seen in my career here," Ms. Frain said. "I think it's really that Mayo Clinic firmly believes that our staff are our most valuable resource." The salary changes will go into effect in January, though the typical timeline for pay increases is March, according to the newspaper. n Bozeman Health chair resigns after physicians' no- confidence vote By Nathan Tucker Renown Health has named Brian Erling, MD, as its next president and CEO, effective Nov. 14. Dr. Erling comes to the Reno, Nev.-based system from Centennial, Colo.-based Centura Health, where he held the roles of chief medical officer, chief clinical officer and — most recently — president and CEO of Penrose-St. Francis Health Services in Colorado Springs. As of this summer, Dr. Erling was no longer in his position with Centura after a six-year tenure with the 17-hospital system. Before then, he served as president of the Alliance Group, a subsidiary of Envision Healthcare. Dr. Erling joins Renown after the system fired its president and CEO, Tony Slonim, MD, in March after an internal in- vestigation. Thomas Graf, MD, served as interim CEO and Sy Johnson served as interim president in the time be- tween Dr. Slonim's firing and the appointment of Dr. Er- ling. With his appointment, Dr. Graf will continue to serve as Renown's chief clinical and quality officer and Mr. John- son will continue to serve as Renown's chief operations officer and chief of staff. n Walmart launches healthcare research institute By Molly Gamble W almart's new Healthcare Research Institute gives custom- ers the chance to enroll in healthcare research, aims to im- prove diversity in clinical trials and support interventions and medications for underrepresented communities. e largest U.S. retailer announced the launch of the Walmart Healthcare Research Institute Oct. 11. It will initially focus on in- clusion in clinical studies on treatments for chronic conditions and treatments that should include members from underrepresented populations, including older adults, rural residents, women and mi- nority populations. Walmart is working with clinical research organizations, pharma- ceutical companies and academic medical centers. e only partners Walmart named in its news release are CTI Clinical Trial & Consult- ing Services and Laina Enterprises. Walmart's digital tool, called My Health Journey, will provide customers with information about clinical trials and participa- tion opportunities. Bentonville, Ark.-based Walmart said the launch of an institute de- voted to clinical trials is in line with its "long-standing commitment to helping expand access to patients and underrepresented popula- tions," demonstrated through offerings like its $4 generic medication program and private label insulin and programs to address social de- terminants of health. Competitors CVS Health and Walgreens also offer access to clinical trials, established in 2021 and 2022, respectively. n

• Cover